NCQA quality measure: Statin Therapy for Patients with Cardiovascular Disease.

What is the SPC measure?

The Statin Therapy for Patients with Cardiovascular Disease (SPC) measure is a key performance metric used by NCQA to assess the quality of care provided to individuals with cardiovascular disease.

The SPC measure is the percentage of US Family Health Plan beneficiaries aged 21-75 with clinical Atherosclerotic Cardiovascular Disease (ASCVD) who have at least 1 fill of a moderate or high-intensity statin medication during the measurement year and the member remained on the statin medication for at least 80% of the treatment period.

Who is excluded?

Our goal is to ensure eligible patients with ASCVD are prescribed a statin unless they meet certain exclusion criteria. Documentation of exclusions each year is important to maintain accurate information and properly exclude patients from this measure calculation.

• During the measurement year: Patients are excluded if, at any point during this period, they are in hospice or palliative care, have a date of death within the measurement period, or have a diagnosis of myalgia, myositis, myopathy, or rhabdomyolysis.
• During the measurement year or the year prior to the measurement year: Patients are excluded if at any point during this period they have a diagnosis of cirrhosis, end-stage renal disease (ESRD) or are on dialysis, have a pregnancy or are receiving in-vitro fertilization (IVF) or have received ≥1 clomiphene prescription, or are ≥66 years old by the last day of the measurement period who have both frailty and advanced illness.
• Any time during the member’s history through the measurement year: Patients are excluded if they have had myalgias or rhabdomyolysis caused by a statin.